Literature DB >> 9690193

Pilot evaluation of hypnotic medication during acute traumatic stress response.

T A Mellman1, P M Byers, J S Augenstein.   

Abstract

Early intervention aimed at secondary prevention is a high priority for posttraumatic stress disorder (PTSD) research. Disrupted sleep may have a role in the initiation and maintenance of PTSD. Three of the participants were recruited from a surgical trauma service, and one had sought treatment in a psychiatric setting. All were within 1-3 weeks of trauma exposure and had acute PTSD symptoms that included disturbed sleep. Temazepam, a benzodiazepine hypnotic, was administered for 5 nights, tapered for 2 nights, and then discontinued. Evaluations 1-week after the medication had been discontinued revealed improved sleep and reduced PTSD severity. These observations suggest an approach that may be clinically useful and a need for more systematic trials.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690193     DOI: 10.1023/A:1024460814230

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  12 in total

1.  Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment.

Authors:  Kathryn M Connor; Jonathan R T Davidson; Richard H Weisler; Wei Zhang; Kurian Abraham
Journal:  Psychopharmacology (Berl)       Date:  2005-12-10       Impact factor: 4.530

2.  Measuring the Effectiveness of Benzodiazepine Prescriptions Control in Community Setting Using Prescription Drug Monitoring Program (PDMP).

Authors:  Ruchita Agrawal; Shikha Verma; Monica Halappanavar
Journal:  Community Ment Health J       Date:  2020-07-14

Review 3.  A Review of Psychopharmacological Interventions Post-Disaster to Prevent Psychiatric Sequelae.

Authors:  Badari Birur; Suresh Bada Math; Rachel E Fargason
Journal:  Psychopharmacol Bull       Date:  2017-01-26

4.  Effects of acute pain medications on posttraumatic stress symptoms in early aftermath of trauma.

Authors:  Aaron S Grau; Hong Xie; Roberta E Redfern; Mohamad Moussa; Xin Wang; Chia-Hao Shih
Journal:  Int Clin Psychopharmacol       Date:  2022-05-02       Impact factor: 2.023

Review 5.  Pharmacotherapy of PTSD: premises, principles, and priorities.

Authors:  Lakshmi N Ravindran; Murray B Stein
Journal:  Brain Res       Date:  2009-03-28       Impact factor: 3.252

Review 6.  Pharmacotherapy for post traumatic stress disorder (PTSD).

Authors:  D J Stein; J C Ipser; S Seedat
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 7.  Treatment-refractory anxiety; definition, risk factors, and treatment challenges.

Authors:  Peter Roy-Byrne
Journal:  Dialogues Clin Neurosci       Date:  2015-06       Impact factor: 5.986

8.  Memory suppression trades prolonged fear and sleep-dependent fear plasticity for the avoidance of current fear.

Authors:  Kenichi Kuriyama; Motoyasu Honma; Takuya Yoshiike; Yoshiharu Kim
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 9.  Disaster Management: Mental Health Perspective.

Authors:  Suresh Bada Math; Maria Christine Nirmala; Sydney Moirangthem; Naveen C Kumar
Journal:  Indian J Psychol Med       Date:  2015 Jul-Sep

Review 10.  Prevention of Post-Traumatic Stress Disorder After Trauma: Current Evidence and Future Directions.

Authors:  Wei Qi; Martin Gevonden; Arieh Shalev
Journal:  Curr Psychiatry Rep       Date:  2016-02       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.